Lynx1 Capital Management LP's Trading History
| KRROKorro Bio | Oct 26, 2026 | Ten Percent Owner | Informative Buy | 884.26K | $23.26M | |
| PASGPassage Bio | Jun 29, 2026 | Ten Percent Owner | Informative Buy | 205.73K | $2.32M | |
| TCRXTScan Therapeutics | Dec 23, 2025 | Ten Percent Owner | Informative Buy | 144.76K | $1.40M | |
| CGEMCullinan Management | Oct 30, 2025 | Ten Percent Owner | Informative Buy | 1.39M | $134.72M | |
| NEUPNeuphoria Therapeutics | Oct 23, 2025 | Ten Percent Owner | Informative Buy | 3.28M | $2.67M |
You May Also Like
Lynx1 Capital Management LP insider profile FAQ
What is the percentage of profitable transactions made by Lynx1 Capital Management LP?
The percentage of profitable transactions made by Lynx1 Capital Management LP is 41%.
What is the average return per transaction made by Lynx1 Capital Management LP?
The average return per transaction made by Lynx1 Capital Management LP is -15.00%.
What stocks does Lynx1 Capital Management LP hold?
Lynx1 Capital Management LP holds: KRRO, PASG, CGEM, TCRX, NEUP stocks.
What was Lynx1 Capital Management LP’s latest transaction?
Lynx1 Capital Management LP’s latest transaction was an Informative Buy of $884.26K.
What was Lynx1 Capital Management LP's most profitable transaction?
Lynx1 Capital Management LP’s most profitable transaction was an Informative Buy of CGEM stock on October 10, 2025. The return on the trade was 109.80%.
What is Lynx1 Capital Management LP's role in Korro Bio?
Lynx1 Capital Management LP's role in Korro Bio is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.